Vicarious Surgical Inc.

Vicarious Surgical Inc. announced that Sarah Romano has resigned from her position as Chief Financial Officer. Her resignation is effective July 22, 2026, or a later date as mutually agreed upon by the company and Ms. Romano. The company stated that her departure was not a result of any disagreement regarding the company's operations, policies, or practices.

Vicarious Surgical Inc. is seeking stockholder approval for an Assignment for the Benefit of Creditors followed by a voluntary dissolution and liquidation. The Board unanimously recommends approval, citing recurring operating losses, negative cash flows, and an inability to secure additional financing or find a buyer. The company warns that it is unlikely stockholders will receive any distributions due to existing liabilities and warrant obligations.

Vicarious Surgical Inc. reported a net loss of $7.329 million for the first quarter of 2026, a significant improvement from the $15.394 million net loss in the same period last year, primarily due to reduced operating expenses. However, the company faces substantial doubt about its ability to continue as a going concern, with current cash and investments of $3.682 million expected to fund operations only through the second quarter of 2026. The company's Class A common stock was delisted from the NYSE and now trades on the OTCQB Venture Market.